Calls › JPM › Oct 13, 2026

JPM Neutral JPMorgan Chase & Co. · Financial Services

Reaction justified; miss is cosmetic.

Published Oct 13, 2026 · Horizon 3-6 months Audited

Edgenone claimed

Evidence7/10

Entry (close)

$334.30 2026-10-12

Since publish

+0.5% to 2026-10-27

vs SPY

+1.5%

3-month verdict

Closes 2027-01-11

Thesis

JPM's Q3 miss is optical, not fundamental: a $658M after-tax securities loss (rate-driven AOCI/portfolio item) explains ~$0.18 of the ~$0.33 shortfall, credit improved YoY (provision $2.74B vs $3.40B, NCOs down, smaller reserve build), and management raised FY26 NII guidance to $106.2B. The market's initial -3.9% reaction was an overreaction; the full intraday reversal was the rational verdict. The genuine negatives — a raised expense guide ($108.6B) and an adjusted EPS pace below consensus run-rate — cap upside at ~13.6x forward in a 5.2% 10Y yield regime that is compressing bank multiples sector-wide.

Bull case

The core franchise delivered: NII guidance raised twice this year, credit costs fell YoY, adjusted ROTCE is 21%, capital return capacity ($50B authorization) is enormous, and estimates were still rising into the print. If the rate selloff stabilizes — 10Y already off its 5.35% peak — the same higher rates become a pure NII tailwind, estimates hold ~$24-25, and a 13.6x premium multiple re-rates toward 15x, implying ~15-20% upside over 6 months. Compressed 20d vol (9th percentile) suggests the next big move could be up if Q4 confirms the raised guide.

Bear case

Adjusted EPS of $5.75 implies a ~$23 annualized pace vs ~$24-25 consensus, and management just raised expenses by $1.1B — the pattern of a bank whose cost growth is outpacing its revenue beat. The 5.2% 10Y is causing real damage (securities losses, BVPS decline, sector de-rating), more Fed hikes are priced, and Dimon himself warns risks are 'shifting under the surface.' Minimal Q3 buybacks ($664M) at these prices hint management sees better uses for capital — or risk ahead. A de-rating to 11-12x on downward estimate drift implies 10-15% downside.

What would change our mind

Q4 shows expense guidance raised again or NII guidance cut — converts the 'optical miss' thesis into genuine deterioration
Card NCOs break materially above 3.2% or reserve builds re-accelerate
If FY27 EPS estimates (~$25.1) hold while the stock de-rates below ~12x, that confirms multiple compression, not fundamentals — the buying opportunity thesis activates
10Y sustained above ~5.5% with renewed BVPS declines would invalidate the 'rates as tailwind' framing

**JPM round-tripped after the earnings miss.** The key visual is the post-earnings reversal: JPM sold off on the headline miss, then recovered as investors focused on higher NII guidance and benign credit.

Since publication vs SPY · closed horizons are frozen

1 weekfinal

+1.3%

-0.2% raw

1 monthrunning

+1.5%

+0.5% raw

3 monthsrunning

+1.5%

+0.5% raw

6 monthsrunning

+1.5%

+0.5% raw

The full research everything the view rests on

Direct answer to the question asked

The Q3 miss ($5.57 vs ~$5.90 EPS) was driven by a one-time $658M securities loss, while the core driver — NII guidance — was raised and credit was benign-to-better; the intraday reversal from -3.9% to roughly flat was therefore the correct read. However, the quarter is not free: the expense guide was raised by $1.1B and adjusted EPS ($5.75) still trails the ~$6+/quarter run-rate implied by FY26 consensus, so at ~13.6x forward earnings the risk/reward over 3-6 months is balanced, not asymmetric.

Where the edge would come from

What the price assumes

At ~13.6x forward EPS and ~2.5x book, the market prices JPM as the premium large bank delivering ~$24-25 FY26 EPS. Estimates were revised up ~5% over the prior 3 months, so the bar was elevated; the stock entered the print -6.2% over 1 month and -8.5% off highs, with the sector under rate-driven multiple compression (KBW regionals -11% from August peak).

Why the market may be wrong

Consensus may be over-indexing on the first-order NII benefit of higher rates while underpricing the second-order costs: the same 5%+ yield environment that lifted NII guidance also caused the securities loss, a QoQ BVPS decline, and sector de-rating — and markets are pricing further Fed hikes, which historically pressures bank multiples before it helps spreads. Conversely, if rate-driven fears prove overdone, JPM's raised core guidance and 21% adjusted ROTCE argue the current multiple is unjustifiably close to trough-sector levels.

The one thing to watch

Watch the expense line, not the EPS headline: the under-reported $1.1B expense guidance raise (to $108.6B) plus an adjusted quarterly EPS of $5.75 vs a ~$6.10 implied FY26 run-rate means either Q4 must accelerate sharply or estimates drift down — making Q4 expense/NII commentary, not credit, the falsifiable variable for the next 3-6 months.

Key evidence (11)

Q3 2026 GAAP EPS $5.57 vs ~$5.90-5.93 consensus; revenue $50.9B vs ~$51.2B [T1 8-K/press release, 10/13/2026]
Miss driven by $658M after-tax securities loss; ex-item EPS $5.75, adjusted ROTCE 21% [T1 presentation]
FY26 NII guidance raised to $106.2B (from $105.5B); ex-markets NII to $97.2B [T1/T3 CNBC]
FY26 expense guidance raised to $108.6B (from $107.5B) — the under-discussed negative [T3 CNBC]
Credit benign: provision $2.74B vs $3.40B YoY; NCOs $2.2B, down YoY; reserve build only $539M vs $810M LY [T1]
Stock fell ~3.9% to ~$321 premarket, then reversed to roughly flat mid-morning [T4 Yahoo/Seeking Alpha — intraday, unverified close]
Peers diverged same day: GS beat massively (EPS $17.01 vs $12.86), WFC missed revenue — reaction was stock-specific, not sector verdict [T3 CNBC]
Macro: 10Y ~5.20% (peaked ~5.35%, highest since ~2002); Fed at 3.75-4.00% with more hikes priced [T3 CNBC]
Valuation ~13.6x forward, ~2.5x book ($334 vs BVPS $132.30, down QoQ); consensus FY26 EPS ~$24.1-25.0 (sources disagree) [T4 Yahoo/MarketWatch]
FY26 EPS estimates revised up ~5% over 3 months into the print [T4 MarketWatch]
Buyback ambiguity: $50B authorized July 2026 but only $664M repurchased in Q3; BVPS dipped QoQ [T1]

Catalysts and risks

Catalysts

Q4 2026 earnings (mid-January 2027): does NII acceleration close the run-rate gap and does expense growth stabilize
October and December FOMC meetings: a December hike is partially priced; a hawkish surprise extends sector de-rating
10Y Treasury path: sustained move above ~5.35% pressures BVPS and multiples; retreat toward 4.8% is a relief catalyst
Any disclosure on buyback pace acceleration under the $50B authorization
Card NCO trajectory vs the ~3.2% full-year guide

Risks

Higher-for-longer rates cause further securities/AOCI losses and deposit-cost pressure, compressing NII ex-markets
Expense growth above revenue growth (negative jaws) if the $108.6B guide slips again
Credit normalization: card losses elevated at ~3.2% and Dimon flags under-the-surface risks; commercial credit improvement could reverse
Estimate drift: FY26 consensus may be ~5% too high given the $5.75 adjusted quarterly run-rate
Sector beta: 0.80 correlation with BAC and heavy XLF correlation limit idiosyncratic outperformance in a bank selloff

What to watch

Q4 expense commentary and whether $108.6B FY26 guide holds
NII ex-markets trajectory vs the raised $97.2B guide
Buyback run-rate in Q4 — acceleration would signal management confidence at ~2.5x book
10Y yield and AOCI/BVPS direction
December FOMC pricing
Estimate revisions over the next 30 days: downward drift toward ~$23.5 FY26 confirms the run-rate concern

Market snapshot when the call was made 2026-10-12

Price

Return 1w	+0.6%
Return 1m	-6.2%
Return 3m	-2.5%
Return 6m	+7.0%
Return 1y	+11.0%
From 52-week high	-8.5%
Realized vol, 20d	17.2%
SPY 3m / 1y	+3.5% / +15.9%
QQQ 3m / 1y	+3.7% / +22.2%

Technicals

JPM technicals as of 2026-10-12: last close $334.30; 20d SMA 338.57 (bearish); 50d SMA 349.79; 12d EMA 334.72; 26d EMA 339.98; RSI 14 40.8 (balanced); 20d vol 16.7%; volume x0.7 vs 20d avg

Sources (28 · T1 = primary filings)

Want a fresh look at JPM, or another name?

Queue a new deep-research run. Published to the feed when done.

Automated research opinion, published as-is on Oct 13, 2026. Not personalised advice. Figures use end-of-day closes.